Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2007-01-23
2007-01-23
Saoud, Christine J. (Department: 1647)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S252300, C435S320100, C530S350000, C536S023500
Reexamination Certificate
active
10295573
ABSTRACT:
The present invention provides modified cyclic nucleotide gated (CNG) channels. In particularly preferred embodiments, the modified CNG channels exhibit increased sensitivity and specificity for cAMP, as compared to wild-type CNG channels. In additional embodiments, regulation by Ca2+-calmodulin has been removed in the modified CNG channels. Convenient optical methods for detecting changes in cAMP, taking advantage of the Ca2+permeability of the channel are also provided by the present invention. In addition, electrophysiological methods are further provided.
REFERENCES:
patent: 4683195 (1987-07-01), Mullis
patent: 4683202 (1987-07-01), Mullis
patent: 4965188 (1990-10-01), Mullis
patent: 5312928 (1994-05-01), Goldin
patent: 6183974 (2001-02-01), Bringhurst
patent: 2003/0100059 (2003-05-01), Yao et al.
patent: 2255548 (2000-06-01), None
patent: WO 98/58074 (1998-12-01), None
patent: WO 99/25384 (1999-05-01), None
patent: WO 99/35255 (1999-07-01), None
patent: WO 00/71565 (2000-11-01), None
Skolnick et al. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotech 18(1): 34-39, 2000.
Bork, A. Powers and pitfalls in sequence analysis: the 70% hurdle. Genome Res 10: 398-400, 2000.
Doerks et al. Protein annotation: detective work for function prediction. Trends in Genetics 14(6): 248-250, 1998.
Smith et al. The challenges of genome sequence annotation or “The devil is in the details”. Nature Biotech 15: 1222-1223, 1997.
Brenner, S.E. Errors in genome function. Trends in Genetics 15(4): 132-133, 1999.
Bork et al. Go hunting in sequence databases but watch out for the traps. Trends in Genetics. 12(10): 425-427, 1996.
Wells. J.A. Additivity of mutational effects in proteins. Biochemistry 29 (37): 8509-8517, 1990.
Ngo et al. Computational complexity, protein structure prediction, and the Levinthal paradox. The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495, 1994.
Wang et al. Rapid analysis of gene expression (RAGE) facilitates universal expression profiling. Nucleic Acids Res 27(23): 4609-4618, 1999.
Phillips, A., The challenge of gene therapy and DNA delivery. J Pharm Pharmacology 53: 1169-1174, 2001.
Kaufman et al. Blood 94: 3178-3184, 1999.
Bradley et al. Nomenclature for ion channel subunits. Science 294(5549): 2095-2096, 2001.
Broillet et al. Cyclic nucleotide-gated channels. Ann N Y Acad Sci 868: 730-740, 1999.
Gavazzo et al. A point mutation in the pore region alters gating, Ca(2+) blockage, and permeation of olfactory cyclic nucleotide-gated channels. J Gen Physiol 116 : 311-325, 2000.
Grunwald et al. Identification of a domain on the beta-subunit of the rod cGMP-gated cation channel that mediates inhibition by calcium-calmodulin. J Biol Chem 273(15) : 9148-9157, 1998.
Hofmann et al. International Union of Pharmacology, XLII. Compendium of voltage-gated ion channels: cyclic nucleotide-modulated channels. Pharmacol Rev 55(4): 587-589, 2003.
Kaupp et al. Cyclic Nucleotide-gated ion channels. Physiol Rev 82 : 769-824, 2002.
Picco et al. Co-expression of wild-type and mutant olfactory cyclic nucleotide-gated channels: restoration of the native sensitivity to Ca(2+) and Mg(2+) blockage. Neuroreport 12(11) : 2363-2367, 2001.
Trudeau et al. Calcium/calmodulin of olfactory and rod cyclic nucleotide-gated ion channels. J Biol Chem 278(21) : 18705-18708, 2003.
Randrianarison-Jewtoukoff et all. Recombinant adenoviruses as vaccines. Biologicals 23: 145-157, 1995.
Luck et al., Molecular Endocrinology 1991, vol. 5(12): pp. 1880-1886.
Stuart et al., Lancet. 2004, vol. 364(9442): pp. 1343-1360.
Adams et al., “Fluorescence ratio imaging of cyclic AMP in single cells,”Nature, 349:694-697 [1991].
Ahluawalia and Rhoads, “Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction,”Biochem. Pharmacol., 31:665-669 [1992].
Ahn et al., “Effects of selective inhibitors on cyclic nucleotide phospho-dieterases of rabbit aorta,”Biochem. Pharmacol., 38:3331-3339 [1989].
Akita and Kuba, “Functional triads consisting of ryanodine receptors, Ca2+-activated K+channels in bullfrog sympathetic neurons,”J. Gen. Physiol., 116:697-720 [2000].
Alvarez et al., “Regulation of cyclic AMP metabolism in human platelets: Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins,”Mol. Pharmacol., 20:302-309 [1981].
Bacskai et al., Spatially resolved dynamics of cAMP and protein kinase A subunits inAplysiasensory neurons,Science, 260:222-226 [1993].
Baylor et al., “The membrane current of single rod outer segments,”J. Physiol., 288:589-611 [1979].
Beavo, “Multiple isozymes of cyclic nucleotide phosphodieterase,”Adv. Second Messenger Phosphoprot. Res., 22:1-38 [1988].
Beavo, “Cyclic nucleotide phosphodieterases: Functional implications of multiple isoforms,”Physiol. Rev., 75:725-748 [1995].
Bolger et al., “Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene,”Biochem. J., 328:539-548 [1997].
Bolger et al., “A family of human phosphodieterases homologous to theduncelearning and memory gene product ofDrosophila melanogasterare potential targets for antidepressant drugs,”Mol. Cell. Biol., 13:6558-6571 [1993].
Boshart et al., “A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus,”Cell, 41:521-530 [1985].
Bridge et al., “The relationship between charge movements associated with ICaand INa-Coin cardiac myocytes,”Science, 248:376-378 [1990].
Broillet, “A single intracellular cysteine residue is responsible for the activation of the olfactory cyclic nucleotide-gated channel by NO,”J. Biol. Chem., 275:15135-15141 [2000].
Brooker, “Oscillation of cyclic adenosine monophosphate concentration during the myocardial contraction cycle,”Science, 182:933-934 [1973].
Chen et al., “Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1,”Nature, 403:557-560 [2000].
Chen-Izu et al., “G1-dependent localization of β2-adrenergic receptor signaling to L-type Ca2+channels,”Biophys. J., 79:2547-2556 [2000].
Conti et al., “Recent progress in understanding the hormonal regulation of phosphodieterases,”Endocrine Res., 16:370-389 [1995].
Cooper et al., “Ca2+-sensitive adenylyl cyclases,”Adv. Second Messenger Phosphoprotein Res., 32:23-51 [1998].
Cooper et al., “Adenynyl cyclases and the interaction between calcium and cAMP signalling,”Nature, 374:421-424 [1995].
Coste and Grondin, “Characterization of a novel potent and specific inhibitor of type V phosphodiesterase,”Biochem. Pharmacol., 50:1577-1585 [1995].
Davare et al., “A β2adrenergic receptor signaling complex assembled with the Ca2+channel Cav1.2,”Science, 293:98-101 [2001].
Dhallan et al., “Primary structure and functional expression of a cyclic nucleotide-activated channel from olfactory neurons,”Nature, 347:184-187 [1990].
Dijkema, et al., “Cloning and expression of the chromosomal immune interferon gene of the rat,”EMBO J., 4:761-767 [1985].
Drummond and Perrot-Yee, “Enzymatic hydrolysis of adenosine 3′-5′-phosphoric acid,”J. Biol. Chem., 236:1126-1129 [1961].
Epstein et al., “Catalytic and kinetic properties of purified high-affinity cyclic AMP phosphodiesterase from dog kidney,”Arch. Biochem. Biophys., 218:119-133 [1982].
Evans et al., “Muscarinic cholinergic receptors of two cells lines that regulate cyclic AMP metabolism by different molecular mechanisms,”Mol. Pharmacol., 26:395-404 [1984].
Fagan et al., “Adenovirus encoded cyclic nucleotide-gated channels: A new methodology for monitoring cAMP in living cells,”FEBS Lett., 500:85-90 [2001].
Fagan et
Cooper Dermot M. F.
Fagan Kent
Karpen Jeffrey W.
Rich Thomas C.
Schaack Jerome
Lockard Jon M
Medlen & Carrol LLP
Saoud Christine J.
The Regents of the University of Colorado
LandOfFree
Nucleic acids encoding modified olfactory cyclic nucleotide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acids encoding modified olfactory cyclic nucleotide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids encoding modified olfactory cyclic nucleotide... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3754255